CASE STUDY | PRODUCT STRATEGY
Shaping Products for Real-World Adoption
This case study shows how real-world perspectives were incorporated into product and clinical strategy to strengthen adoption, reimbursement potential, and investor relevance, while reducing the risk of costly strategic changes later in development.
Shaping Products for Real-World Adoption
STARTING POINT
A rare disease biopharma preparing its first asset for global development needed to align product strategy with investor expectations, payer requirements, clinical priorities, and future market adoption.
CHALLENGE
The Target Product Profile and clinical strategy had been defined without sufficient real-world input from payers, patients, and healthcare providers, creating risk around adoption and reimbursement.
EXECUTION
JUYMO worked directly with the leadership team to align product strategy with real-world market dynamics. The work included stress-testing the Target Product Profile, mapping adoption barriers, integrating stakeholder insights into development priorities, and refining the value narrative for clinical, payer, and investor audiences.
IMPACT
- Target Product Profile aligned with regulatory and market adoption requirements
- Clinical endpoints refined to support payer and healthcare provider decision-making
- Investor narrative strengthened for fundraising discussions
- Reduced risk of late-stage strategic pivots